Article Details

AzurRx BioPharma Submits an Investigational New Drug Application for Niclosamide as ...

Retrieved on: 2021-09-08 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

AzurRx BioPharma Submits an Investigational New Drug Application for Niclosamide as .... View article details on hiswai:

Excerpt

(NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up